Biogen Inc. Common Stock (BIIB)

Health Care·equity

$225.71

+3.33% today

Prices delayed about 15 minutes · cached page, can be an hour old or more

Market Census Score

56/ 100

Score level

Above average

6 of 6 checks had data

Smart-money score is on the low side; price trend is one of its highest-scoring factors; score for how it compares with the broader market is on the high side.

BIIB scores higher than 78% of the 1,101 tickers we compare it with (Health Care).

As of 10 October 2026, Biogen Inc. Common Stock (BIIB) scores 56 out of 100 on the Market Census six-factor composite, which puts it at the Above average score level. The score is made from six named factors: price trend, strength vs the market, company finances, insider trades, market mood and recent momentum. It records what they read on 10 October 2026, and it is not investment advice.

Updated 10 October 2026 · scores usually change about once a day

Key statistics

Market fields as reported. An em-dash means we hold no value for this ticker — most of the universe has no daily price or volume read.

Relative volume: 0.80× 30-day average
52-week range: 138.00 – 230.49
Market cap: $31.84B
Earnings date: 28 Oct 2026

Volume: 815,008
Avg. volume (30d): 1,024,359

Open: 220.62
Previous close: 218.43
Day's range (regular session): 219.22 – 227.20

The last trade can be an extended-hours trade, so it can sit outside the regular-session range.

Shown without a peer ranking — we hold no percentile for these yet, so there is nothing here to locate them against.

Beta: 0.10
P/E (TTM): 38.42
EPS (TTM): 5.65

Score breakdown · six named factors

Price trend

Strength vs the market

Company finances

Insider trades

Market mood

Recent momentum

Each bar is one part of the score, from 0 to 100. Read what the score means.

Premium data held for BIIB

4 SEC Form 4 insider transactions in the last 90 daysPremium

Counts of rows Market Census holds for BIIB. A dash in the factor table above means that factor has no data for this ticker — it is not a locked value. Compare plans

What the score says about BIIB right now

Biogen Inc. Common Stock (BIIB) currently scores 56/100 on the Market Census six-factor composite, at the Above average score level. BIIB is +3.33% on the day and +2.65% over five sessions as of the most recent tick. Above average sits a bit above the middle. The data for BIIB leans good, with some weak spots. BIIB's strongest factor is price trend at 81/100 — a very strong read on which way the price has been going. The weakest factor is insider trades at 10/100 — a well below average read on insider buying and selling. Insider filings for BIIB lean toward selling; on a thinly filed name a few filings can set this reading.

Generated from the six-factor breakdown above. Changes when the underlying scores do, usually about once a day. More on what the score means.

See BIIB in the scanner

This page is free to read with no account at all. Signing up takes an email and a password: a free account runs the scanner on the top 10 scored rows of any scan, keeps one saved screen, a 5-ticker watchlist, and opens 12 ticker detail pages a day. The card is what starts a 30-day Premium trial — $0 that day, then $19.99/month from day 30, cancel online any time before then — and that is what turns on every matching row instead of the first 10, alerts, the 200-ticker watchlist and recent insider buys (SEC Form 4).

Create your account →Share on X Embed this score